BioMelbourne Network submission regarding R&D Tax Incentive
August 2018 On behalf of the members, BioMelbourne Network has made a submission to Treasury regarding the proposed changes to the R&D Tax Incentive. In terms of our overall consideration of the proposed changes to the R&D Tax…
BioMelbourne Network Policy Principles – 2018 State Election
May 2018 The biotechnology, medical technology and pharmaceutical sector in Victoria is vibrant and growing but yet to reach its full potential contribution to the Victorian economy. Historical support from governments has allowed the sector to grow, now…
BioMelbourne Network submission to the Policy Consultation Paper – Visa Simplification: Transforming Australia’s Visa System
October 2017 “Australia’s visa system must remain globally competitive to attract talent to build future industries and transition to a knowledge-led economy” Health is a global market and access to global talent is critical for healthcare innovation. Companies…
Pharmaceutical Manufacturing: Driving Competitive Advantage for Victoria
September 2017 Continued Discussions : Pharmaceutical Manufacturing: Driving Competitive Advantage for Victoria BioMelbourne Network convened a roundtable with Minister Wade Noonan, Minister Philip Dalidakis and 14 pharmaceutical and biotechnology companies who currently manufacture or develop products for manufacture…
Joint Statement on Skilled Migration Visa Changes
July 2017 Restoration on skilled visas welcomed across medical technology, biotechnology and pharmaceutical sector. The restoration of key occupations for the medical technology, research and pharmaceutical sector to the skilled migration visa list has been welcomed by six…
BioMelbourne Network Welcomes Revisions to Skilled Migration Visas
July 2017 Revisions to the skilled migration list have been welcomed by many BioMelbourne Network members across the biotechnology, medical technology and pharmaceutical sector. The restoration of occupations such as life scientist, biotechnologist, CEO/General Manager, and biochemist to…
Department of Immigration Roundtable Discussion (May 2017)
BioMelbourne Network CEO, Dr Krystal Evans attended a technology industries roundtable discussion with the Department of Immigration and the Department of Industry regarding skilled migration and the decision to abolish the 457 visa program. The medical technology, biotechnology and…
Joint statement on the Research & Development Tax Incentive (April 2017)
18 April 2017 Don’t rip the guts out of Australian medical research commercialisation Commercialisation of Australian medical research is under serious threat if the package of measures put by the ‘Ferris, Finkel, Fraser’ Review of the Research &…
Changes to the R&D Tax Incentive: Putting a handbrake on innovation (September 2016)
September 2016 The R&D Tax Incentive Review paper was released on 28th of September, making recommendations on changes to the scheme – including a proposed $2Million cap on the annual cash refund payable under the R&D Tax Incentive.…
BioMelbourne Network CEO on MELBOURNE 4.0 Steering Committee
September 2015 The Committee for Melbourne has announced the members of the MELBOURNE 4.0 Steering Committee. The Steering Committee will drive the MELBOURNE 4.0 engagement process and ensure concrete policy initiatives are identified. Reflective of the Committee for…
MTP Connect Competitiveness Plan Consultation Lunch (September 2016)
September 2016 A new pathway for engagement with the Federal Government on issues concerning the sector is through the recently established Industry Growth Centres. Last week, BioMelbourne Network held a CEO lunch with Sue MacLeman, CEO MTPConnect as…
Nature 2016 Research Translation and Innovation Symposium (August 2016)
August 2016 Leadership | Culture | Communication | Collaboration | Human Capital | Scale These were the strong themes emerging from the Nature 2016 Research Translation and Innovation Symposium held in Canberra last week on Thursday 11th of…
